Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Kees Okkersen; Cecilia Jimenez-Moreno; Stephan Wenninger; Ferroudja Daidj; Jeffrey Glennon; Sarah Cumming; Roberta Littleford; Darren G. Monckton; Hanns Lochmuller; Michael Catt; Catharina G. Faber; Adrian Hapca; Peter T. Donnan; Grainne Gorman; Guillaume Bassez; Benedikt Schoser; Hans Knoop; Shaun Treweek; Baziel G. M. van Engelen; OPTIMISTIC Consortium

doi:10.1016/S1474-4422(18)30203-5

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

Kees Okkersen^*, Cecilia Jimenez-Moreno, Stephan Wenninger, Ferroudja Daidj, Jeffrey Glennon, Sarah Cumming, Roberta Littleford, Darren G. Monckton, Hanns Lochmuller, Michael Catt, Catharina G. Faber, Adrian Hapca, Peter T. Donnan, Grainne Gorman, Guillaume Bassez, Benedikt Schoser, Hans Knoop, Shaun Treweek, Baziel G. M. van Engelen, OPTIMISTIC Consortium

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	671-680
Number of pages	10
Journal	Lancet Neurology
Volume	17
Issue number	8
DOIs	https://doi.org/10.1016/S1474-4422(18)30203-5
Publication status	Published - 1 Aug 2018

Keywords

NEUROMUSCULAR DISEASES
PHYSICAL-ACTIVITY
OUTCOME MEASURES
FOLLOW-UP
FEASIBILITY
IMPAIRMENT
PREDICTORS
MANAGEMENT
ADULTS
FALLS

Access to Document

10.1016/S1474-4422(18)30203-5

Cite this

Okkersen, K., Jimenez-Moreno, C., Wenninger, S., Daidj, F., Glennon, J., Cumming, S., Littleford, R., Monckton, D. G., Lochmuller, H., Catt, M., Faber, C. G., Hapca, A., Donnan, P. T., Gorman, G., Bassez, G., Schoser, B., Knoop, H., Treweek, S., van Engelen, B. G. M., & OPTIMISTIC Consortium (2018). Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurology, 17(8), 671-680. https://doi.org/10.1016/S1474-4422(18)30203-5

Okkersen, Kees ; Jimenez-Moreno, Cecilia ; Wenninger, Stephan ; Daidj, Ferroudja ; Glennon, Jeffrey ; Cumming, Sarah ; Littleford, Roberta ; Monckton, Darren G. ; Lochmuller, Hanns ; Catt, Michael ; Faber, Catharina G. ; Hapca, Adrian ; Donnan, Peter T. ; Gorman, Grainne ; Bassez, Guillaume ; Schoser, Benedikt ; Knoop, Hans ; Treweek, Shaun ; van Engelen, Baziel G. M. ; OPTIMISTIC Consortium. / Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. In: Lancet Neurology. 2018 ; Vol. 17, No. 8. pp. 671-680.

@article{8fe0129e029a47568941a2d913a573c3,

title = "Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial",

keywords = "NEUROMUSCULAR DISEASES, PHYSICAL-ACTIVITY, OUTCOME MEASURES, FOLLOW-UP, FEASIBILITY, IMPAIRMENT, PREDICTORS, MANAGEMENT, ADULTS, FALLS",

author = "Kees Okkersen and Cecilia Jimenez-Moreno and Stephan Wenninger and Ferroudja Daidj and Jeffrey Glennon and Sarah Cumming and Roberta Littleford and Monckton, {Darren G.} and Hanns Lochmuller and Michael Catt and Faber, {Catharina G.} and Adrian Hapca and Donnan, {Peter T.} and Grainne Gorman and Guillaume Bassez and Benedikt Schoser and Hans Knoop and Shaun Treweek and {van Engelen}, {Baziel G. M.} and {OPTIMISTIC Consortium}",

year = "2018",

month = aug,

day = "1",

doi = "10.1016/S1474-4422(18)30203-5",

language = "English",

volume = "17",

pages = "671--680",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Science",

number = "8",

}

Okkersen, K, Jimenez-Moreno, C, Wenninger, S, Daidj, F, Glennon, J, Cumming, S, Littleford, R, Monckton, DG, Lochmuller, H, Catt, M, Faber, CG, Hapca, A, Donnan, PT, Gorman, G, Bassez, G, Schoser, B, Knoop, H, Treweek, S, van Engelen, BGM & OPTIMISTIC Consortium 2018, 'Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial', Lancet Neurology, vol. 17, no. 8, pp. 671-680. https://doi.org/10.1016/S1474-4422(18)30203-5

Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. / Okkersen, Kees; Jimenez-Moreno, Cecilia; Wenninger, Stephan; Daidj, Ferroudja; Glennon, Jeffrey; Cumming, Sarah; Littleford, Roberta; Monckton, Darren G.; Lochmuller, Hanns; Catt, Michael; Faber, Catharina G.; Hapca, Adrian; Donnan, Peter T.; Gorman, Grainne; Bassez, Guillaume; Schoser, Benedikt; Knoop, Hans; Treweek, Shaun; van Engelen, Baziel G. M.; OPTIMISTIC Consortium.

In: Lancet Neurology, Vol. 17, No. 8, 01.08.2018, p. 671-680.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial

AU - Okkersen, Kees

AU - Jimenez-Moreno, Cecilia

AU - Wenninger, Stephan

AU - Daidj, Ferroudja

AU - Glennon, Jeffrey

AU - Cumming, Sarah

AU - Littleford, Roberta

AU - Monckton, Darren G.

AU - Lochmuller, Hanns

AU - Catt, Michael

AU - Faber, Catharina G.

AU - Hapca, Adrian

AU - Donnan, Peter T.

AU - Gorman, Grainne

AU - Bassez, Guillaume

AU - Schoser, Benedikt

AU - Knoop, Hans

AU - Treweek, Shaun

AU - van Engelen, Baziel G. M.

AU - OPTIMISTIC Consortium

PY - 2018/8/1

Y1 - 2018/8/1

KW - NEUROMUSCULAR DISEASES

KW - PHYSICAL-ACTIVITY

KW - OUTCOME MEASURES

KW - FOLLOW-UP

KW - FEASIBILITY

KW - IMPAIRMENT

KW - PREDICTORS

KW - MANAGEMENT

KW - ADULTS

KW - FALLS

U2 - 10.1016/S1474-4422(18)30203-5

DO - 10.1016/S1474-4422(18)30203-5

M3 - Article

VL - 17

SP - 671

EP - 680

JO - Lancet Neurology

JF - Lancet Neurology

SN - 1474-4422

IS - 8

ER -